PL376721A1 - Pochodne acylowe 5-(2-(4-(1,2-benzoizotiazol-3-ilo)-1-piperazynylo) etylo)-6-chloro-1,3-dihydro-2H-indol-2-onu o działaniu neuroleptycznym - Google Patents
Pochodne acylowe 5-(2-(4-(1,2-benzoizotiazol-3-ilo)-1-piperazynylo) etylo)-6-chloro-1,3-dihydro-2H-indol-2-onu o działaniu neuroleptycznymInfo
- Publication number
- PL376721A1 PL376721A1 PL376721A PL37672103A PL376721A1 PL 376721 A1 PL376721 A1 PL 376721A1 PL 376721 A PL376721 A PL 376721A PL 37672103 A PL37672103 A PL 37672103A PL 376721 A1 PL376721 A1 PL 376721A1
- Authority
- PL
- Poland
- Prior art keywords
- benzisothiazole
- indol
- piperazinyl
- dihydro
- chloro
- Prior art date
Links
- 125000002252 acyl group Chemical group 0.000 title 1
- 230000000701 neuroleptic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42084302P | 2002-10-24 | 2002-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376721A1 true PL376721A1 (pl) | 2006-01-09 |
Family
ID=32176638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376721A PL376721A1 (pl) | 2002-10-24 | 2003-10-13 | Pochodne acylowe 5-(2-(4-(1,2-benzoizotiazol-3-ilo)-1-piperazynylo) etylo)-6-chloro-1,3-dihydro-2H-indol-2-onu o działaniu neuroleptycznym |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7019009B2 (pl) |
| EP (1) | EP1556378B1 (pl) |
| JP (1) | JP2006505578A (pl) |
| KR (1) | KR100755625B1 (pl) |
| CN (1) | CN100340557C (pl) |
| AR (1) | AR041695A1 (pl) |
| AT (1) | ATE383357T1 (pl) |
| AU (1) | AU2003269331B2 (pl) |
| BR (1) | BR0315516A (pl) |
| CA (1) | CA2500485C (pl) |
| CO (1) | CO5550441A2 (pl) |
| CY (1) | CY1107300T1 (pl) |
| DE (1) | DE60318602T2 (pl) |
| DK (1) | DK1556378T3 (pl) |
| ES (1) | ES2297200T3 (pl) |
| MX (1) | MXPA05002734A (pl) |
| NO (1) | NO20052475L (pl) |
| NZ (1) | NZ566615A (pl) |
| PL (1) | PL376721A1 (pl) |
| PT (1) | PT1556378E (pl) |
| RU (1) | RU2005112254A (pl) |
| TW (1) | TW200418850A (pl) |
| WO (1) | WO2004037819A1 (pl) |
| ZA (1) | ZA200502109B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007517014A (ja) * | 2003-12-31 | 2007-06-28 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Ｎ−置換ピペリジン及びピペラジン誘導体 |
| HUE033442T2 (en) | 2009-06-25 | 2017-11-28 | Alkermes Pharma Ireland Ltd | Heterocyclic compounds for the treatment of neurological and psychological disorders |
| WO2010151711A1 (en) * | 2009-06-25 | 2010-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds |
| NZ604423A (en) | 2010-06-24 | 2015-01-30 | Alkermes Pharma Ireland Ltd | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| JP7384812B2 (ja) | 2018-03-05 | 2023-11-21 | アルカームス ファーマ アイルランド リミテッド | アリピプラゾール投与戦略 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206366A (en) * | 1992-08-26 | 1993-04-27 | Pfizer Inc. | Process for preparing aryl piperazinyl-heterocyclic compounds |
| US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
| PT790236E (pt) * | 1996-02-13 | 2004-04-30 | Pfizer | Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona |
| DE69923692T2 (de) * | 1998-08-20 | 2006-03-23 | Sumitomo Pharmaceuticals Co., Ltd. | Wachstumshormon-freisetzende oxindolderivate |
-
2003
- 2003-10-13 AU AU2003269331A patent/AU2003269331B2/en not_active Ceased
- 2003-10-13 EP EP03751112A patent/EP1556378B1/en not_active Expired - Lifetime
- 2003-10-13 CN CNB2003801017404A patent/CN100340557C/zh not_active Expired - Fee Related
- 2003-10-13 JP JP2004546256A patent/JP2006505578A/ja not_active Withdrawn
- 2003-10-13 ES ES03751112T patent/ES2297200T3/es not_active Expired - Lifetime
- 2003-10-13 CA CA2500485A patent/CA2500485C/en not_active Expired - Fee Related
- 2003-10-13 DE DE60318602T patent/DE60318602T2/de not_active Expired - Fee Related
- 2003-10-13 WO PCT/IB2003/004519 patent/WO2004037819A1/en active IP Right Grant
- 2003-10-13 PT PT03751112T patent/PT1556378E/pt unknown
- 2003-10-13 NZ NZ566615A patent/NZ566615A/en not_active IP Right Cessation
- 2003-10-13 RU RU2005112254/04A patent/RU2005112254A/ru not_active Application Discontinuation
- 2003-10-13 MX MXPA05002734A patent/MXPA05002734A/es not_active Application Discontinuation
- 2003-10-13 DK DK03751112T patent/DK1556378T3/da active
- 2003-10-13 PL PL376721A patent/PL376721A1/pl not_active Application Discontinuation
- 2003-10-13 BR BR0315516-1A patent/BR0315516A/pt not_active IP Right Cessation
- 2003-10-13 KR KR1020057006938A patent/KR100755625B1/ko not_active Expired - Fee Related
- 2003-10-13 AT AT03751112T patent/ATE383357T1/de not_active IP Right Cessation
- 2003-10-21 US US10/689,773 patent/US7019009B2/en not_active Expired - Fee Related
- 2003-10-22 AR ARP030103846A patent/AR041695A1/es unknown
- 2003-10-23 TW TW092129426A patent/TW200418850A/zh unknown
-
2005
- 2005-03-14 ZA ZA200502109A patent/ZA200502109B/en unknown
- 2005-04-22 CO CO05038502A patent/CO5550441A2/es not_active Application Discontinuation
- 2005-05-23 NO NO20052475A patent/NO20052475L/no not_active Application Discontinuation
-
2008
- 2008-03-12 CY CY20081100276T patent/CY1107300T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR041695A1 (es) | 2005-05-26 |
| CA2500485C (en) | 2010-03-23 |
| DE60318602T2 (de) | 2009-01-15 |
| ES2297200T3 (es) | 2008-05-01 |
| JP2006505578A (ja) | 2006-02-16 |
| WO2004037819A1 (en) | 2004-05-06 |
| CN1705663A (zh) | 2005-12-07 |
| DK1556378T3 (da) | 2008-03-17 |
| KR20050065618A (ko) | 2005-06-29 |
| EP1556378B1 (en) | 2008-01-09 |
| HK1081185A1 (en) | 2006-05-12 |
| CN100340557C (zh) | 2007-10-03 |
| CY1107300T1 (el) | 2012-11-21 |
| CO5550441A2 (es) | 2005-08-31 |
| DE60318602D1 (de) | 2008-02-21 |
| US20040138232A1 (en) | 2004-07-15 |
| NZ566615A (en) | 2009-08-28 |
| US7019009B2 (en) | 2006-03-28 |
| NO20052475D0 (no) | 2005-05-23 |
| KR100755625B1 (ko) | 2007-09-04 |
| NO20052475L (no) | 2005-07-25 |
| AU2003269331A1 (en) | 2004-05-13 |
| ZA200502109B (en) | 2006-05-31 |
| ATE383357T1 (de) | 2008-01-15 |
| CA2500485A1 (en) | 2004-05-06 |
| AU2003269331B2 (en) | 2010-02-18 |
| BR0315516A (pt) | 2005-08-23 |
| PT1556378E (pt) | 2008-02-21 |
| MXPA05002734A (es) | 2005-05-23 |
| TW200418850A (en) | 2004-10-01 |
| EP1556378A1 (en) | 2005-07-27 |
| RU2005112254A (ru) | 2006-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2252895A1 (en) | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist | |
| NO933093L (no) | Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on hydroklorid | |
| CA2252898A1 (en) | Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one(=ziprasidone), its preparation and its use as dopamine d2 antagonist | |
| DK1398328T3 (da) | Hydroxyalkyl stivelsesderivater | |
| AP2005003250A0 (en) | Heterocyclic substituted piperazines for the treatment of schizophrenia. | |
| PL375790A1 (pl) | Nowe heterocykliczne pochodne fluoroglikozydu, leki zawierające te związki oraz ich zastosowanie | |
| PL372969A1 (pl) | Pochodne tiazolu i oksazolu modulujące aktywność PPAR | |
| FI956279L (fi) | Menetelmiä ja välituotteita 5-/2-(4-(bentsoisotiatsol-3-yyli)piperatsin-1-yyli)etyyli/-6-kloori-1,3-dihydroindol-2-onin valmistamiseksi | |
| PT1103545E (pt) | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-totil-piridin-3-il)-isobutiramida | |
| ATE395333T1 (de) | 4-phenylpiperazinyl, -piperidinyl und - tetrahydropyridyl-derivate als dopamin d4- antagonisten | |
| PL376721A1 (pl) | Pochodne acylowe 5-(2-(4-(1,2-benzoizotiazol-3-ilo)-1-piperazynylo) etylo)-6-chloro-1,3-dihydro-2H-indol-2-onu o działaniu neuroleptycznym | |
| AU2003260882A1 (en) | Heterocyclic substituted piperazines for the treatment of schizophrenia | |
| DE59906902D1 (de) | Herbizide 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidin-2,4-dione | |
| ATE254600T1 (de) | Prodrogen von 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl ethyl)-6-chloro-1,3-dihydro-2h-indol- 2-on | |
| IL158929A0 (en) | Oxazol/thiazol derivatives as activators of the hppar-alpha receptor | |
| SI1556378T1 (sl) | Acilni derivati 5-(2-(4-(1,2-benzizotiazol-3-il)-1-piperaznil)etil)-6-kloro-1,3-dihidro -2H-indol-2-ona z nevrolepticno aktivnostjo | |
| AU2003215158A1 (en) | 2-(5-(5-carbamimidoyl-1h-heteroaryl))-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors | |
| AU2003297408A1 (en) | Thiazole compounds as integrin receptor antagonists derivatives | |
| CA2236940A1 (en) | Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole | |
| PL354991A1 (pl) | 2-(4,6-dimetylo-pirymidyn-2-yloksy)-3-[2-(3,4-dimetoksyfenylo) etoksy]-3,3-difenylopropionian sodu i jego zastosowanie jako antagonisty endoteliny | |
| HU0600868D0 (en) | 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation | |
| HUP9902404A3 (en) | Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-choloro-1,3-dihydro-2(2h)-indol-2-one (-ziprasidone), its preparation and its use as dopamine d2 antagonist | |
| AU2001290743A1 (en) | Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide | |
| HK1073465A (en) | 5-substituted 1, 1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors | |
| IS6696A (is) | N-[5-[[[5-alkýl-2-oxazólýl]metýl]þíó]-2-þíazólýl]karboxamíð tálmar sýklínháðra kínasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |